Smith Charles O, Wang Yves T, Nadtochiy Sergiy M, Miller James H, Jonas Elizabeth A, Dirksen Robert T, Nehrke Keith, Brookes Paul S
Department of Biochemistry, University of Rochester Medical Center, Rochester, New York, USA.
Department of Anesthesiology and Perioperative Medicine, University of Rochester Medical Center, Rochester, New York, USA.
FASEB J. 2018 Jun 4;32(11):fj201800139R. doi: 10.1096/fj.201800139R.
Controversy surrounds the molecular identity of mitochondrial K channels that are important for protection against cardiac ischemia-reperfusion injury. Although K1.2 (sodium-activated potassium channel encoded by Kcn2) is necessary for cardioprotection by volatile anesthetics, electrophysiological evidence for a channel of this type in mitochondria is lacking. The endogenous physiological role of a potential mito-K1.2 channel is also unclear. In this study, single channel patch-clamp of 27 independent cardiac mitochondrial inner membrane (mitoplast) preparations from wild-type (WT) mice yielded 6 channels matching the known ion sensitivity, ion selectivity, pharmacology, and conductance properties of K1.2 (slope conductance, 138 ± 1 pS). However, similar experiments on 40 preparations from Kcnt2 mice yielded no such channels. The K opener bithionol uncoupled respiration in WT but not Kcnt2 cardiomyocytes. Furthermore, when oxidizing only fat as substrate, Kcnt2 cardiomyocytes and hearts were less responsive to increases in energetic demand. Kcnt2 mice also had elevated body fat, but no baseline differences in the cardiac metabolome. These data support the existence of a cardiac mitochondrial K1.2 channel, and a role for cardiac K1.2 in regulating metabolism under conditions of high energetic demand.-Smith, C. O., Wang, Y. T., Nadtochiy, S. M., Miller, J. H., Jonas, E. A., Dirksen, R. T., Nehrke, K., Brookes, P. S. Cardiac metabolic effects of K1.2 channel deletion and evidence for its mitochondrial localization.
线粒体钾通道的分子身份存在争议,该通道对预防心脏缺血再灌注损伤很重要。虽然K1.2(由Kcn2编码的钠激活钾通道)对挥发性麻醉剂的心脏保护作用是必需的,但线粒体中这种类型通道的电生理证据仍然缺乏。潜在的线粒体K1.2通道的内源性生理作用也不清楚。在本研究中,对来自野生型(WT)小鼠的27个独立的心脏线粒体内膜(线粒体膜片)制剂进行单通道膜片钳实验,得到了6个通道,其离子敏感性、离子选择性、药理学和电导率特性与K1.2已知特性相符(斜率电导率,138±1 pS)。然而,对来自Kcnt2小鼠的40个制剂进行的类似实验未得到此类通道。钾通道开放剂硫双二氯酚使WT而非Kcnt2心肌细胞的呼吸解偶联。此外,当仅以脂肪作为底物进行氧化时,Kcnt2心肌细胞和心脏对能量需求增加的反应较弱。Kcnt2小鼠的体脂也有所升高,但心脏代谢组没有基线差异。这些数据支持心脏线粒体K1.2通道的存在,以及心脏K1.2在高能量需求条件下调节代谢的作用。——史密斯,C.O.,王,Y.T.,纳托奇伊,S.M.,米勒,J.H.,乔纳斯,E.A.,迪克森,R.T.,内尔克,K.,布鲁克斯,P.S.K1.2通道缺失对心脏代谢的影响及其线粒体定位的证据。